Latest / Lexington News Today | 2 Min News | The Daily News Now!
Moderna’s mRNA Flu Shot Approved | Lexington News
Moderna’s new mRNA flu shot, mFlusiva, just got FDA approval—specifically for folks 50 and older—and could be hitting shelves soon. Built on the same tech that saved us from COVID, this vaccine promises faster updates as flu strains mutate. Early data shows strong protection, especially for seniors, with side effects like soreness and fatigue being mild. After a brief regulatory pause, the FDA reversed course, backing this game-changing tool in our annual flu defense. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.